Tiziana Life Sciences (TLSA) Total Current Liabilities (2017 - 2025)
Tiziana Life Sciences (TLSA) posted quarterly Total Current Liabilities of $11.2 million for Q4 2025, up 52.54% year-over-year from $7.3 million in Q4 2024, and up 52.54% quarter-over-quarter from $7.3 million in Q4 2024.
Tiziana Life Sciences (TLSA) Total Current Liabilities (2017 - 2025) Analysis & Trends
Tiziana Life Sciences' Total Current Liabilities history runs 9 years deep, the most recent figure standing at $11.2 million for Q4 2025.
- In Q4 2025, Total Current Liabilities rose 52.54% year-over-year to $11.2 million; the TTM figure through Dec 2025 stood at $11.2 million (up 52.54% YoY), while the FY2025 annual figure was $11.2 million, up 52.54% from the prior year.
- Total Current Liabilities for Q4 2025 stood at $11.2 million, up from $7.3 million in the prior quarter.
- The five-year high for Total Current Liabilities was $11.2 million in Q4 2025, with the low at $6.5 million in Q4 2023.
- The 5-year median for Total Current Liabilities is $7.3 million (2024), against an average of $7.9 million.
- The sharpest annual moves came in 2022 and 2025: Total Current Liabilities decreased 11.7% in 2022, then surged 52.54% in 2025.
- Tiziana Life Sciences' Total Current Liabilities stood at $7.5 million in 2021, then retreated by 11.7% to $6.7 million in 2022, then declined by 1.86% to $6.5 million in 2023, then gained by 12.37% to $7.3 million in 2024, then soared by 52.54% to $11.2 million in 2025.
- Business Quant data shows TLSA's Total Current Liabilities at $11.2 million in Q4 2025, $7.3 million in Q4 2024, and $6.5 million in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 3.94 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 5.53 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 1.58 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 2.53 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 2.12 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 1.51 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 2.49 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 438.74 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 630.93 Mn |
| 10 | Tiziana Life Sciences | 133.66 Mn | 129.65 Mn | - | 11.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 11.21 Mn |
| Dec 31, 2024 | 7.35 Mn |
| Dec 31, 2023 | 6.54 Mn |
| Dec 31, 2022 | 6.66 Mn |
| Dec 31, 2021 | 7.55 Mn |
| Dec 31, 2020 | 7.98 Mn |
| Dec 31, 2019 | 7.35 Mn |
| Dec 31, 2018 | 6.40 Mn |
| Dec 31, 2017 | 4.75 Mn |